FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
McKnight's Long-Term Care News23h
FDA approves Zepbound for sleep apnea in patients with obesity
The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).
Hosted on MSN17h
Pharma Stock Roundup: NVO's Obesity Study Failure, FDA Nod to PFE, LLY
Novo Nordisk NVO announced disappointing data from a phase III study on a novel obesity candidate. The FDA approved Eli Lilly ...
Forbes17h
Trump’s Cabinet And Key Jobs: Miami-Dade Commissioner Kevin Cabrera and Billionaire Tilman Fertitta Among Latest Nominees
Pending Senate approval, Long’s addition will seemingly end IRS Commissioner Danny Werfel’s term early (his term was slated to end in 2027). Long is a former auctioneer and has worked as a ...
Forbes17h
Trump’s Cabinet And Key Jobs: Billionaire Tilman Fertitta And ‘The Apprentice’ Producer Mark Burnett Among Latest Nominees
Pending Senate approval, Long’s addition will seemingly end IRS Commissioner Danny Werfel’s term early (his term was slated to end in 2027). Long is a former auctioneer and has worked as a ...